India Screens Over 7.29 Crore for Sickle Cell Disease
The National Sickle Cell Anaemia Elimination Mission highlights the urgent need for lifelong care as nearly 2 million in India live with the disease.
India has the highest sickle cell disease burden outside Africa, with 2 million affected.
The National Sickle Cell Mission has diagnosed over 2.5 lakh individuals and identified 20.5 lakh carriers.
Public-private partnerships are crucial for expanding access to specialized care in rural areas.
India is facing a significant public health challenge with sickle cell disease (SCD), affecting nearly 2 million individuals, particularly in rural and tribal areas. The emotional and financial toll on families is profound, as recurring painful episodes lead to frequent hospital visits and missed workdays. The country accounts for about 16% of global annual SCD births, underscoring the need for accessible and specialized healthcare services.
The National Sickle Cell Anaemia Elimination Mission has made strides in addressing this issue, screening over 7.29 crore people and diagnosing more than 2.5 lakh individuals with SCD. Additionally, 20.5 lakh carriers have been identified. While these achievements are commendable, they represent just the beginning of a long journey towards ensuring that those diagnosed receive timely treatment and continuous support.
To effectively manage SCD, patients require comprehensive care that includes early diagnosis, pain management, and crisis intervention. In response, wellness hubs have been established in collaboration with state governments in regions such as Rajasthan, Maharashtra, and Madhya Pradesh. These centers aim to provide essential healthcare services closer to those in need, particularly in underserved communities. Moreover, the healthcare system must adapt to incorporate new treatments and innovations, with support from organizations like the World Health Organization (WHO).
Collaboration between the public and private sectors is vital for enhancing access to specialized SCD services. Initiatives like Ayushman Arogya Mandirs can serve as community wellness hubs, facilitating screening and follow-up care. Private partners can also help by training healthcare workers and improving supply chains for essential medicines, ensuring that quality care reaches beyond urban centers.
Looking ahead, India can utilize data from the national mission to enhance long-term management of SCD. Implementing digital health systems and patient registries will enable better monitoring of treatment adherence and facilitate regular follow-ups. By integrating these digital solutions with local healthcare facilities, India can transform initial screening efforts into a coordinated system of ongoing patient care. The ultimate goal is to provide every individual diagnosed with SCD with consistent, affordable, and specialized care, allowing them to pursue education and employment with dignity.
